Clinical trial
Exploratory Evaluation of the Potential for Long-term Retention of Gadolinium in the Bones of Patients Who Have Received Gadolinium Based Contrast Agents According to Their Medical History
NCT01853163 is registered in ClinicalTrials.gov with Navitas Life Sciences GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Evaluation of the Potential for Long-term Retention of Gadolinium in the Bones of Patients Who Have Received Gadolinium Based Contrast Agents According to Their Medical History
- Lead sponsor
- Navitas Life Sciences GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 6, 2013
- Completion date
- December 17, 2018
- Enrollment
- 92 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
focus: long-term retention of gadolinium-based contrast agent